G01N 2800/166
Cataract
G01N2800/166 (Cataract) appears on 7 US grants and 11 published applications in this corpus.
Search patents in G01N- Granted patents
- 7
- Published applications
- 11
- Assignees
- 10
- Inventors
- 22
- Latest grant
- 25 Jun 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Method for analyzing isoaspartic acid and mass spectrometer25 Jun 2024US 12,020,919 B2National Institute of Advanced Industrial Science and Technology
- Brain-specific angiogenesis inhibitor 1 (BAI1) antibodies and uses thereof31 Oct 2023US 11,802,151 B2Code Biotherapeutics, Inc.
- Hereditary cataract status in canines based on HSF4 gene marker28 Feb 2012US 8,124,337 B2Animal Health Trust
- Method of identifying calcium-binding sites in gamma-crystallin useful for management of cataract4 May 2010US 7,711,497 B2Council of Scientific and Industrial Research
- Method for the identification of agents that inhibit or promote cataracts and uses thereof23 Jan 2007US 7,166,472 B2The General Hospital Corporation
- Method for analyzing isoaspartic acid and mass spectrometer11 Aug 2022US 2022/0254621 A1National Institute of Advanced Industrial Science and Technology
- Brain-Specific Angiogenesis Inhibitor 1 (BAI1) Antibodies And Uses Thereof6 May 2021US 2021/0130448 A1Genisphere, LLC
- Detection of alpha, beta-dicarbonyl compounds with fluorogenic probes23 Jun 2016US 2016/0178637 A1University of Warwick
- Hereditary cataract status in canines based on hsf4 gene marker1 Jul 2010US 2010/0168211 A1Animal Health Trust
- Methods of Identifying Disease Biomarkers in the Lense of the Eye29 Apr 2010US 2010/0105098 A1
Most cited
By later US patents
- Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions9US 6,864,239 B2Theratechnologies Inc. · 2005
- Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions9US 7,094,761 B2Theratechnologies Inc. · 2006
- Brain-specific angiogenesis inhibitor 1 (BAI1) antibodies and uses thereof1US 11,802,151 B2Code Biotherapeutics, Inc. · 2023